Increasing Losartan for Optimal Cardiovascular Protection

Rationale for Dose Escalation

• The American College of Cardiology recommends losartan 100 mg once daily as the target dose for optimal cardiovascular protection and blood pressure control, with 50 mg representing only 50% of the target dose 1
• At 75 mg, the patient is receiving 75% of the target dose, leaving room for further therapeutic benefit, according to the American College of Cardiology guidelines 1

Evidence Supporting 100 mg Dosing

• The American College of Cardiology/American Heart Association performance measures specify that patients should receive at least 50% of target dose, with 100 mg being the full target dose for losartan 1

Monitoring Plan

• The American College of Cardiology recommends reassessing blood pressure within 2-4 weeks to evaluate response after increasing losartan to 100 mg 2
• The target blood pressure is <130/80 mmHg for most patients, according to the American Heart Association and supported by Praxis Medical Insights 3, 2
• Monitoring of serum potassium and renal function is necessary, particularly when combining ARBs with diuretics, as recommended by Praxis Medical Insights 2

If Blood Pressure Remains Elevated

• The American College of Cardiology recommends adding a calcium channel blocker as the third agent before considering a fourth drug if blood pressure remains uncontrolled on losartan 100 mg plus HCTZ 25 mg, as suggested by Praxis Medical Insights 2
• If still uncontrolled on three agents at optimal doses, adding spironolactone 25 mg daily as the preferred fourth agent is recommended by Praxis Medical Insights 2
• Verifying medication adherence is necessary before adding additional agents, according to Praxis Medical Insights 2